Grisdale KA, Armstrong TS. Peripheral neuropathy. In Camp-Sorrell D, Hawkins RA, eds. Clinical Manual for the Oncology Advanced Practice Nurse, 3rd ed. Pittsburgh, PA: Oncology Nursing Society; 2014:1137-1149.
Haryani H, Fetzer SJ, Ching LW, Hsu Y. Chemotherapy-induced peripheral neuropathy assessment tools: a systematic review. Oncology Nursing Forum. 2017;44(3):E111-E122.
Loprinzi CL, Qin R, Dakhil SR, et al. Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial. (N08CB/Alliance). J Clin Oncol. 2015;33(30):3416-3422.
National Cancer Institute. Nerve Problems (Peripheral Neuropathy) and Cancer Treatment. 8/9/18. Accessed at https://www.cancer.gov/about-cancer/treatment/side-effects/nerve-problems on September 19, 2019.
National Cancer Center Network (NCCN). Adult Cancer Pain. Version 3.2019. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf on September 19, 2019.
Oncology Nursing Society (ONS). Symptom interventions: Peripheral neuropathy. Accessed at https://www.ons.org/pep/peripheral-neuropathy on September 19, 2019.
Piccolo J, Kolesar JM. Prevention and treatment of chemotherapy-induced peripheral neuropathy. Am J Health Syst Pharm. 2014;7:119-1125.
Smith EM, Zanville N. Peripheral neuropathy. In Brown CG, ed. A Guide to Oncology Symptom Management. 2nd ed. Pittsburgh, PA. Oncology Nursing Society; 2015:531-549.
Yust-Katz S, Gilbert MR. Neurologic Complications In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia: Elsevier, 2020:822-844.e6